Infection in Pulmonary Vascular Disease (iPVD) Consortium

The Infection in Pulmonary Vascular Disease (iPVD) Consortium’s primary focus is to study infectious diseases from a basic science and mechanisms perspective. This is distinct from the pharmaceutical and therapeutics angle of the IDDI. 

Virtual Symposium by the iPVD Consortium

One of the iPVD Consortium's most successful outputs is its Virtual Symposium webinar series, which has continued into 2024 after delivering six webinars on inflammation and infection in 2023. The series, hosted by PVRI, is a global education programme highlighting the latest research on infections in PVD. The webinars proide a great opportunity for international speakers to participate, present, and ask questions of our fantastic committee. Webinars are held on the last Wednesday of the month at 15:00 BST/GMT, and recordings are available on our website.

The Microbes webinar series 

• Microbiome and microbial metabolites, March 2024
  • Microbiome and pulmonary circulation: where are we going? (Moderator introduction), Suellen D Oliveira, University of Illinois at Chicago, USA 
  • Pro-inflammatory gut microbiome in PAH patients, Thenappan Thenappan, University of Minnesota, USA 
  • Insights into the role of microbiome metabolites in PH, Imad Al Ghouleh, University of Pittsburgh, USA
• Bacteria, May 2024
  • Unveiling the burden: Post-tuberculosis PVD in South Africa, Friedrich Thienemann, University of Cape Town, South Africa

Upcoming webinars in the series - see our Events page to book your place.

• August 2024: Clinical Aspects
• November 2024: Co-infection

The Inflammation and Infection webinar series

• Fungi, November 2023
  • Beyond parasites and viruses - fungi & PH, Sharilyn Almodovar (Moderator), Texas Tech University, USA 
  • Pulmonary paracoccidioidomycosis-induced pulmonary hypertension, Alexandre Todorovic Fabro, University of São Paulo, Brazil
     
• Viruses, September 2023
  • When SARS-CoV-2 meets the pulmonary circulation, Navneet Dhillon (Moderator), University of Kansas, USA 
  • Endothelial progenitor cells: A potential biomarker for evaluating endothelial health in Post Covid patients, Olga Tura-Ceide, University of Barcelona, Spain
     
• Parasites, July 2023
  • Schistosomiasis-associated PAH, Rudolf Oliveira (Moderator), Federal University of São Paulo, Brazil 
  • Schistosomiasis-associated PAH: when the Schisto camouflage fails, Brian Graham, University of San Francisco, USA
     
• The role of Tregs, June 2023
  • Inaugural series - inflammation and the pulmonary circulation: the good, the bad and the ugly (moderator introduction), Vinicio de Jesus Perez, Stanford University, USA 
  • Adaptive immunity: role of Tregs in pulmonary arterial hypertension, Rajkumar Savai, Max Planck Institute for Heart and Lung Research, Germany
     
• Inflamed lung, March 2023
  • Inaugural series - inflammation and the pulmonary circulation: the good, the bad and the ugly, Peter Nyasulu, University of the Witwatersrand, South Africa 
  • Inflammatory lung microenvironment in lung cancer-associated PH, Rajkumar Savai, Max Planck Institute for Heart and Lung Research, Germany
     
• The Endothelium, February 2023
  • Infection and PH - why have we started the iPVD consortium?, Ghazwan Butrous, University of Kent, UK 
  • Inaugural series - inflammation and the pulmonary circulation: the good, the bad and the ugly, Suellen Darc Oliveira, University of Illinois at Chicago, USA 
  • scRNAseq reveals inflammatory EC phenotypes in PAH, Kewal Asosingh, Cleveland Clinic, USA